Class information for:
Level 1: ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//NPM ALK

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5941 1486 31.1 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
39 32196 MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANAPLASTIC LARGE CELL LYMPHOMA Author keyword 201 53% 18% 268
2 LYMPHOMATOID PAPULOSIS Author keyword 114 67% 7% 103
3 NPM ALK Author keyword 39 64% 3% 38
4 ALCL Author keyword 35 46% 4% 57
5 CD30 Author keyword 31 25% 7% 108
6 KI 1 LYMPHOMA Author keyword 29 65% 2% 28
7 KI 1 Author keyword 19 61% 1% 20
8 T25 TRANSLOCATION Author keyword 18 89% 1% 8
9 ALK Author keyword 16 18% 5% 81
10 ANAPLASTIC LYMPHOMA KINASE Author keyword 16 23% 4% 59

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANAPLASTIC LARGE CELL LYMPHOMA 201 53% 18% 268 Search ANAPLASTIC+LARGE+CELL+LYMPHOMA Search ANAPLASTIC+LARGE+CELL+LYMPHOMA
2 LYMPHOMATOID PAPULOSIS 114 67% 7% 103 Search LYMPHOMATOID+PAPULOSIS Search LYMPHOMATOID+PAPULOSIS
3 NPM ALK 39 64% 3% 38 Search NPM+ALK Search NPM+ALK
4 ALCL 35 46% 4% 57 Search ALCL Search ALCL
5 CD30 31 25% 7% 108 Search CD30 Search CD30
6 KI 1 LYMPHOMA 29 65% 2% 28 Search KI+1+LYMPHOMA Search KI+1+LYMPHOMA
7 KI 1 19 61% 1% 20 Search KI+1 Search KI+1
8 T25 TRANSLOCATION 18 89% 1% 8 Search T25+TRANSLOCATION Search T25+TRANSLOCATION
9 ALK 16 18% 5% 81 Search ALK Search ALK
10 ANAPLASTIC LYMPHOMA KINASE 16 23% 4% 59 Search ANAPLASTIC+LYMPHOMA+KINASE Search ANAPLASTIC+LYMPHOMA+KINASE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KI 1 LYMPHOMA 313 79% 13% 200
2 T2 5P23 Q35 102 86% 3% 51
3 MONOCLONAL ANTIBODY ALK1 60 75% 3% 43
4 T2 5P23 Q35 TRANSLOCATION 58 88% 2% 28
5 NPM ALK 44 44% 5% 75
6 PAPULOSIS 41 39% 6% 84
7 KI 1 34 65% 2% 33
8 KINASE ALK 33 64% 2% 32
9 P80NPM ALK 32 85% 1% 17
10 CD30 POSITIVE LYMPHOPROLIFERATIVE DISORDERS 32 70% 2% 26

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma 2011 50 91 85%
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features 2000 402 136 71%
Anaplastic large cell lymphoma, ALK-positive 2012 22 64 47%
Pathobiology of ALK(+) anaplastic large-cell lymphoma 2007 83 132 55%
Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous 2015 1 119 62%
SPECTRUM OF PRIMARY CUTANEOUS CD30 (KI-1)-POSITIVE LYMPHOPROLIFERATIVE DISORDERS - A PROPOSAL FOR CLASSIFICATION AND GUIDELINES FOR MANAGEMENT AND TREATMENT 1993 189 34 91%
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature 2007 44 13 69%
Anaplastic lymphoma kinase proteins in growth control and cancer 2004 130 289 43%
Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy 2008 76 294 42%
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 2009 20 76 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ONCOGENESIS SIGNALING HEMATOPOIET CELLS 6 71% 0.3% 5
2 LRF IMMUNODIAGNOST UNIT 6 42% 0.7% 11
3 ONCOGEN FUS GENES PROT UNIT 3 100% 0.2% 3
4 LEUKEMOGENESIS 3 33% 0.5% 7
5 NEW YORK CANC 2 38% 0.3% 5
6 CNRS UPR2163 2 67% 0.1% 2
7 GRP ETUD LYMPHOMES MALINS 2 67% 0.1% 2
8 IMMUNODIAGNOST UNIT 2 33% 0.3% 5
9 NUFFIELD CLIN BIOCHEM CELLULAR SCI 2 29% 0.3% 5
10 CELLULAR SCI 2 12% 0.9% 13

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000229855 SOLUBLE CD30//SCD30//CD30
2 0.0000183386 CRIZOTINIB//ANAPLASTIC LYMPHOMA KINASE//ALK
3 0.0000170873 FEBRILE ULCERONECROTIC MUCHA HABERMANN DISEASE//PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA//PITYRIASIS LICHENOIDES
4 0.0000133733 ANGIOIMMUNOBLASTIC T CELL LYMPHOMA//PERIPHERAL T CELL LYMPHOMA//ANGIOIMMUNOBLASTIC LYMPHOMA
5 0.0000129940 CUTANEOUS B CELL LYMPHOMA//PRIMARY CUTANEOUS B CELL LYMPHOMA//CUTANEOUS LYMPHOID HYPERPLASIA
6 0.0000112868 MYCOSIS FUNGOIDES//CUTANEOUS T CELL LYMPHOMA//SEZARY SYNDROME
7 0.0000112537 FOLLICULAR DENDRITIC CELL SARCOMA//INTERDIGITATING DENDRITIC CELL SARCOMA//HISTIOCYTIC SARCOMA
8 0.0000101905 EOSINOPHILIC ULCER//RIGA FEDE DISEASE//NEONATAL TEETH
9 0.0000091557 HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA
10 0.0000091155 LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA